DeepChek® Assay INTEGRASE Genotyping and Drug Resistance
Introduction
The DeepChek® Assay Integrase Genotyping and Drug Resistance is intended to be used for amplifying relevant portion of the human immunodeficiency virus type one (HIV-1) integrase gene from input RNA extracted from plasma, serum or whole blood samples. The codons spanning positions 20 to 280 of the integrase (INT) gene in the pol open reading frame are amplified. This nucleic acid amplification method might aid in the determination of antiviral resistance in clinical samples from HIV-infected patients. The DeepChek® INT Assay is a variant of the DeepChek® PR/RT Assay.
Examples of Reports
For NGS Sequencing (DeepChek®-HIV CE-IVD)
For SANGER Sequencing (Viroscore® CE-IVD)
Ordering Information
| Product | Reference |
|---|---|
|
DeepChek® Assay INTEGRASE Genotyping and Drug Resistance (CE-IVD) |
122A24 |
|
DeepChek® Assay INTEGRASE Genotyping and Drug Resistance (RUO) |
102C24 |
|
DeepChek® HIV Software (CE-IVD) |
S-12-023 (HL) |
|
ViroScore-HIV Annual Software License (CE-IVD) |
S-09-014 |